# A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT

> **NCT03716011** · NA · UNKNOWN · sponsor: **JW Medical Systems Ltd** · enrollment: 2700 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** EXCROSSAL

## Key facts

- **NCT ID:** NCT03716011
- **Lead sponsor:** JW Medical Systems Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-20
- **Primary completion:** 2021-12-20
- **Final completion:** 2025-12-20
- **Target enrollment:** 2700 (ESTIMATED)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03716011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03716011, "A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03716011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*